Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30064724HIVENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TVIS30064725HIVENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TVIS30064726HIVENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TVIS30064727HIVENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TVIS20002837HPVENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TVIS20045835HPVENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TVIS20019209HPVENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TVIS44022568HTLV-1ENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TVIS44050551HTLV-1ENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TVIS44050552HTLV-1ENSG00000112062.13protein_codingMAPK14NoNo1432B4E0K5
L7RSM2
Q16539
TCGA Plot Options
Drug Information
GeneMAPK14
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0001019
UniProt IDQ16539
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830